Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
暂无分享,去创建一个
Y. Doki | M. Mori | T. Mizushima | T. Kudo | J. Nishimura | Ho Min Kim | H. Akamatsu | R. Nezu | T. Hata | K. Danno | C. Matsuda | Yoshihito Ide | Koki Tamai | T. Ohnishi | Y. Fujie | Shunji Morita | S. Yoshioka | Multi-Center Clinical Study Group of Osaka | Colorectal Cancer Collaborative Group | H. Kim